Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

StemCells Company Profile (NASDAQ:STEM)

Consensus Ratings for StemCells (NASDAQ:STEM) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $4.75 (361.17% upside)

Analysts' Ratings History for StemCells (NASDAQ:STEM)
Show:
DateFirmActionRatingPrice TargetDetailsShare
1/26/2015Chardan CapitalInitiated CoverageBuy$2.25ViewTweet This Rating  Share This Rating on StockTwits
12/22/2014Maxim GroupSet Price TargetBuy$5.00ViewTweet This Rating  Share This Rating on StockTwits
10/7/2014Maxim GroupInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
7/2/2014Brinson PatrickInitiated CoverageOutperform$7.00ViewTweet This Rating  Share This Rating on StockTwits
6/20/2014Maxim GroupBoost Price TargetBuy$2.50 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
6/17/2014Chardan CapitalReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
5/19/2014Maxim GroupReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
4/17/2014Edison Investment ResearchNeutralViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/31/2013 forward)